Corti, Davide
Vir Biotechnology (Switzerland)
28 papers on CoChatORCID 0000-0002-5797-1364
Most cited papers
- Verified
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Walls, A. C., Miranda, M. C., Schäfer, A., Pham, M. N., Greaney, A., Arunachalam, P. S., Navarro, M.-J., Tortorici, M. A., Rogers, K., O’Connor, M. A., et al. (2021) · Cell
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 185
- Verified
Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge
Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008) · Journal of Virology
SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies
Cited by 134
- Verified
Tackling COVID-19 with neutralizing monoclonal antibodies
Corti, D., Purcell, L. A., Snell, G., & Veesler, D. (2021) · Cell
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 78
- Verified
A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
Lee, J., Stewart, C., Schäfer, A., Leaf, E. M., Park, Y.-J., Asarnow, D., Powers, J. M., Treichel, C., Sprouse, K. R., Corti, D., et al. (2024) · Nature Communications
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 23
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free